The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy
Open accessAbstract
Nanoparticulate drug delivery systems (Nano-DDSs) have emerged as possible solution to the obstacles of anticancer drug delivery. However, the clinical outcomes and translation are restricted by several drawbacks, such as low drug loading, premature drug leakage and carrier-related toxicity. Recently, pure drug nano-assemblies (PDNAs), fabricated by the self-assembly or co-assembly of pure drug molecules, have attracted considerable attention. Their facile and reproducible preparation technique helps to remove the bottleneck of nanomedicines including quality control, scale-up production and clinical translation. Acting as both carriers and cargos, the carrier-free PDNAs have an ultra-high or even 100% drug loading. In addition, combination therapies based on PDNAs could possibly address the most intractable problems in cancer treatment, such as tumor metastasis and drug resistance. In the present review, the latest development of PDNAs for cancer treatment is overviewed. First, PDNAs are classified according to the composition of drug molecules, and the assembly mechanisms are discussed. Furthermore, the co-delivery of PDNAs for combination therapies is summarized, with special focus on the improvement of therapeutic outcomes. Finally, future prospects and challenges of PDNAs for efficient cancer therapy are spotlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Interfaces and the driving force of hydrophobic assembly
Chandler, D. (2005) · Nature · doi:10.1038/nature04162 · Cited by 3,591
A view on drug resistance in cancer
Vasan, N., Baselga, J., & Hyman, D. M. (2019) · Nature · doi:10.1038/s41586-019-1730-1 · Cited by 2,770
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
Celli, J. P., Spring, B. Q., Rizvi, I., Evans, C. L., Samkoe, K. S., Verma, S., Pogue, B. W., & Hasan, T. (2010) · Chemical Reviews · doi:10.1021/cr900300p · Cited by 2,324
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Mu, J., Wang, G., Yan, H., Li, H., Wang, X., Gao, E., Hou, C., Pham, A. T. C., Wu, L., Zhang, Q., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03032-2 · Cited by 1,436
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Galluzzi, L., Humeau, J., Buqué, A., Zitvogel, L., & Kroemer, G. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0413-z · Cited by 1,349
Schirrmacher, V. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4661 · Cited by 1,296
Iversen, T.-G., Skotland, T., & Sandvig, K. (2011) · Nano Today · doi:10.1016/j.nantod.2011.02.003 · Cited by 1,239
Robertson, C. A., Evans, D. H., & Abrahamse, H. (2009) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2009.04.001 · Cited by 1,198
Innovative Strategies for Hypoxic‐Tumor Photodynamic Therapy
Li, X., Kwon, N., Guo, T., Liu, Z., & Yoon, J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201805138 · Cited by 1,175
Therapeutic developments in pancreatic cancer: current and future perspectives
Neoptolemos, J. P., Kleeff, J., Michl, P., Costello, E., Greenhalf, W., & Palmer, D. H. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0005-x · Cited by 1,170
Sawyers, C. (2004) · Nature · doi:10.1038/nature03095 · Cited by 1,165
Hsiang, Y. H., Lihou, M. G., & Liu, L. F. (1989) · PubMed · Cited by 1,028
pH-Responsive Nanoparticles for Drug Delivery
Gao, W., Chan, J. M., & Farokhzad, O. C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100253e · Cited by 1,025
Sekone, A. K., Chen, Y.-B., Lu, M.-C., Chen, W.-K., Liu, C.-A., & Lee, M.-T. (2016) · Nanoscale Research Letters · doi:10.1186/s11671-015-1209-4 · Cited by 1,016
Current Challenges in Cancer Treatment
Zugazagoitia, J., Guedes, C., Ponce, S., Ferrer, I., Molina-Pinelo, S., & Paz-Ares, L. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.03.026 · Cited by 926
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
(2015) · New England Journal of Medicine · doi:10.1056/nejmc1509660 · Cited by 872
Recent progress in tumor pH targeting nanotechnology
Lee, E. S., Gao, Z., & Bae, Y. H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.003 · Cited by 866
Light in diagnosis, therapy and surgery
Yun, S. H., & Kwok, S. J. J. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0008 · Cited by 793
Clinical Translation of Nanomedicine
Min, Y., Caster, J. M., Eblan, M. J., & Wang, A. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00116 · Cited by 772
Emerging combination strategies with phototherapy in cancer nanomedicine
Xie, Z., Fan, T., An, J., Choi, W., Duo, Y., Ge, Y., Zhang, B., Nie, G., Xie, N., Zheng, T., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00215a · Cited by 716
Müller, R. H., Gohla, S., & Keck, C. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.007 · Cited by 702
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Min, Y., Roche, K. C., Tian, S., Eblan, M. J., McKinnon, K. P., Caster, J. M., Chai, S., Herring, L. E., Zhang, L., Zhang, T., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.113 · Cited by 701
Cancer nanomedicine: from targeted delivery to combination therapy
Xu, X., Ho, W., Zhang, X., Bertrand, N., & Farokhzad, O. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.001 · Cited by 693
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Hu, C.-M. J., & Zhang, L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.008 · Cited by 686
Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics
Tang, W., Fan, W., Lau, J., Deng, L., Shen, Z., & Chen, X. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00805a · Cited by 605
Extracellular purines, purinergic receptors and tumor growth
Di Virgilio, F., & Adinolfi, E. (2017) · Oncogene · doi:10.1038/onc.2016.206 · Cited by 559
Heinhuis, K. M., Ros, W., Kok, M., Steeghs, N., Beijnen, J. H., & Schellens, J. H. M. (2019) · Annals of Oncology · doi:10.1093/annonc/mdy551 · Cited by 557
Cai, Y., Xue, F., Fleming, C., Yang, J., Ding, C., Ma, Y., Liu, M., Zhang, H.-G., Zheng, J., Xiong, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms11354 · Cited by 531
Rao, L., Bu, L., Xu, J., Cai, B., Yu, G., Yu, X., He, Z., Huang, Q., Li, A., Guo, S., et al. (2015) · Small · doi:10.1002/smll.201502388 · Cited by 513
Applications of π-π stacking interactions in the design of drug-delivery systems
Zhuang, W.-R., Wang, Y., Cui, P.-F., Xing, L., Lee, J., Kim, D., Jiang, H.-L., & Oh, Y.-K. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.014 · Cited by 508
Simple Peptide‐Tuned Self‐Assembly of Photosensitizers towards Anticancer Photodynamic Therapy
Liu, K., Xing, R., Zou, Q., Ma, G., Möhwald, H., & Yan, X. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201509810 · Cited by 503
Massarelli, E., William, W., Johnson, F., Kies, M., Ferrarotto, R., Guo, M., Feng, L., Lee, J. J., Tran, H., Kim, Y. U., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4051 · Cited by 490
Cancer and the tumor microenvironment: a review of an essential relationship
Mbeunkui, F., & Johann, D. J. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0881-9 · Cited by 487
Classification of current anticancer immunotherapies
Galluzzi, L., Vacchelli, E., Pedro, J.-M. B.-S., Buqué, A., Senovilla, L., Baracco, E. E., Bloy, N., Castoldi, F., Abastado, J.-P., Agostinis, P., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2998 · Cited by 468
Mathematical modeling of drug dissolution
Siepmann, J., & Siepmann, F. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.044 · Cited by 459
Cancer theranostics: the rise of targeted magnetic nanoparticles
Cole, A. J., Yang, V. C., & David, A. E. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.03.001 · Cited by 425
Drug resistance in cancer: Principles of emergence and prevention
Komarova, N. L., & Wodarz, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501870102 · Cited by 414
Dissecting the Molecular Mechanism of Apoptosis during Photothermal Therapy Using Gold Nanoprisms
Pérez-Hernández, M., del Pino, P., Mitchell, S. G., Moros, M., Stepien, G., Pelaz, B., Parak, W. J., Gálvez, E. M., Pardo, J., & de la Fuente, J. M. (2015) · ACS Nano · doi:10.1021/nn505468v · Cited by 398
A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
Wang, T., Wang, D., Yu, H., Feng, B., Zhou, F., Zhang, H., Zhou, L., Jiao, S., & Li, Y. (2018) · Nature Communications · doi:10.1038/s41467-018-03915-4 · Cited by 391
Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2
Zak, K. M., Grudnik, P., Magiera, K., Dömling, A., Dubin, G., & Holak, T. A. (2017) · Structure · doi:10.1016/j.str.2017.06.011 · Cited by 388
Dai, J., Lin, S., Cheng, D., Zou, S., & Shuai, X. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201103806 · Cited by 382
Extremely high conductivity observed in the triple point topological metal MoP
Kumar, N., Sun, Y., Nicklas, M., Watzman, S. J., Young, O., Leermakers, I., Hornung, J., Klotz, J., Gooth, J., Manna, K., et al. (2019) · RePEc: Research Papers in Economics · Cited by 374
Persidis, A. (1999) · Nature Biotechnology · doi:10.1038/5289 · Cited by 372
Cai, K., He, X., Song, Z., Yin, Q., Zhang, Y., Uckun, F. M., Jiang, C., & Cheng, J. (2015) · Journal of the American Chemical Society · doi:10.1021/ja513034e · Cited by 363
Cancer‐Associated, Stimuli‐Driven, Turn on Theranostics for Multimodality Imaging and Therapy
Li, X., Kim, J., Yoon, J., & Chen, X. (2017) · Advanced Materials · doi:10.1002/adma.201606857 · Cited by 362
Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics
Gong, F., Yang, N., Wang, X., Zhao, Q., Chen, Q., Liu, Z., & Cheng, L. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100851 · Cited by 359
Prodrug-based nanoparticulate drug delivery strategies for cancer therapy
Luo, C., Sun, J., Sun, B., & He, Z. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.008 · Cited by 352
Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
Kuai, R., Yuan, W., Son, S., Nam, J., Xu, Y., Fan, Y., Schwendeman, A., & Moon, J. J. (2018) · Science Advances · doi:10.1126/sciadv.aao1736 · Cited by 352
The structure and mechanical behavior of ice
SCHULSON, E. M. (1999) · JOM · doi:10.1007/s11837-999-0206-4 · Cited by 345
Xing, R., Zou, Q., Yuan, C., Zhao, L., Chang, R., & Yan, X. (2019) · Advanced Materials · doi:10.1002/adma.201900822 · Cited by 322
Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy
Sun, B., Luo, C., Zhang, X., Guo, M., Sun, M., Yu, H., Chen, Q., Yang, W., Wang, M., Zuo, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11193-x · Cited by 319
Carrier-Free, Chemophotodynamic Dual Nanodrugs via Self-Assembly for Synergistic Antitumor Therapy
Zhang, R., Xing, R., Jiao, T., Ma, K., Chen, C., Ma, G., & Yan, X. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b02416 · Cited by 318
Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review
Thakkar, S., Sharma, D., Kalia, K., & Tekade, R. K. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.09.009 · Cited by 316
Modulating Hypoxia via Nanomaterials Chemistry for Efficient Treatment of Solid Tumors
Liu, Y., Jiang, Y., Zhang, M., Tang, Z., He, M., & Bu, W. (2018) · Accounts of Chemical Research · doi:10.1021/acs.accounts.8b00214 · Cited by 307
Yang, Y., Sun, B., Zuo, S., Li, X., Zhou, S., Li, L., Luo, C., Liu, H., Cheng, M., Wang, Y., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc1725 · Cited by 307
Phuengkham, H., Ren, L., Shin, I. W., & Lim, Y. T. (2019) · Advanced Materials · doi:10.1002/adma.201803322 · Cited by 306
Repair of and checkpoint response to topoisomerase I-mediated DNA damage
Pommier, Y., Redon, C., Rao, V. A., Seiler, J. A., Sordet, O., Takemura, H., Antony, S., Meng, L., Liao, Z., Kohlhagen, G., et al. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2003.08.016 · Cited by 302
Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade
Yu, S., Wang, C., Yu, J., Wang, J., Lu, Y., Zhang, Y., Zhang, X., Hu, Q., Sun, W., He, C., et al. (2018) · Advanced Materials · doi:10.1002/adma.201801527 · Cited by 294
Nanomaterials for cancer immunotherapy
Song, W., Musetti, S. N., & Huang, L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.017 · Cited by 281
Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine
Turubanova, V. D., Balalaeva, I. V., Mishchenko, T. A., Catanzaro, E., Alzeibak, R., Peskova, N. N., Efimova, I., Bachert, C., Mitroshina, E. V., Krysko, O., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0826-3 · Cited by 281
Garg, A. D., & Agostinis, P. (2014) · Photochemical & Photobiological Sciences · doi:10.1039/c3pp50333j · Cited by 276
Zhu, T., Shi, L., Yu, C., Dong, Y., Qiu, F., Shen, L., Qian, Q., Zhou, G., & Zhu, X. (2019) · Theranostics · doi:10.7150/thno.32867 · Cited by 264
Heym, B., Honoré, N., Schurra, C., Cole, S. T., Heym, B., Truffot-Pernot, C., Grosset, J. H., Banerjee, A., Jacobs, W. R., & van Embden, J. D. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91338-2 · Cited by 263
Li, Y., Liu, G., Ma, J., Lin, J., Lin, H., Su, G., Chen, D., Ye, S., Chen, X., Zhu, X., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.011 · Cited by 255
ROS-responsive drug delivery systems for biomedical applications
Tao, W., & He, Z. (2018) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2017.11.002 · Cited by 255
Potential impact of invasive surgical procedures on primary tumor growth and metastasis
Alieva, M., van Rheenen, J., & Broekman, M. L. D. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9896-8 · Cited by 246
Self-Delivery Nanomedicine for O2-Economized Photodynamic Tumor Therapy
Zhao, L.-P., Zheng, R.-R., Chen, H.-Q., Liu, L.-S., Zhao, X.-Y., Liu, H.-H., Qiu, X.-Z., Yu, X.-Y., Cheng, H., & Li, S.-Y. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c00047 · Cited by 232
Anticancer drug development: the grand challenges
Hait, W. N. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3144 · Cited by 230
An RNA toolbox for cancer immunotherapy
Pastor, F., Berraondo, P., Etxeberria, I., Frederick, J., Sahin, U., Gilboa, E., & Melero, I. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.132 · Cited by 229
Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics
Chen, Q., Liu, G., Liu, S., Su, H., Wang, Y., Li, J., & Luo, C. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.10.009 · Cited by 229
Niu, D., Jiang, Y., Ji, L., Ouyang, G., & Liu, M. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201900607 · Cited by 226
DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
Bodley, A. L., Liu, L. F., Israel, M., Seshadri, R., Koseki, Y., Giuliani, F. C., Kirschenbaum, S., Silber, R., & Potmĕsil, M. (1989) · PubMed · Cited by 225
A Tubular DNA Nanodevice as a siRNA/Chemo‐Drug Co‐delivery Vehicle for Combined Cancer Therapy
Wang, Z., Song, L., Liu, Q., Tian, R., Shang, Y., Liu, F., Liu, S., Zhao, S., Han, Z., Sun, J., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202009842 · Cited by 223
Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion
D’Alterio, C., Scala, S., Sozzi, G., Roz, L., & Bertolini, G. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.019 · Cited by 219
Feng, B., Niu, Z., Hou, B., Zhou, L., Li, Y., & Yu, H. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201906605 · Cited by 215
Quantitative self-assembly prediction yields targeted nanomedicines
Shamay, Y., Shah, J., Işık, M., Mizrachi, A., Leibold, J., Tschaharganeh, D. F., Roxbury, D., Budhathoki-Uprety, J., Nawaly, K., Sugarman, J. L., et al. (2018) · Nature Materials · doi:10.1038/s41563-017-0007-z · Cited by 214
Ling, Y. H., el-Naggar, A. K., Priebe, W., & Perez-Soler, R. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09073-x · Cited by 213
Zhang, L., Dermawan, K., Jin, M., Liu, R., Zheng, H., Xu, L., Zhang, Y., Cai, Y., Chu, Y., & Xiong, S. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.07.013 · Cited by 209
Her2-positive breast cancer: Herceptin and beyond
Dean-Colomb, W., & Esteva, F. J. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.09.013 · Cited by 208
Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect
Bocci, G., & Kerbel, R. S. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.64 · Cited by 207
Su, C., Liu, Y., Li, R., Wu, W., Fawcett, J. P., & Gu, J. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.06.008 · Cited by 200
Yang, J., & Hu, L. (2019) · Medicinal Research Reviews · doi:10.1002/med.21530 · Cited by 190
Electrostatic Assembly of Nanoparticles and Biomacromolecules
Sastry, M., Rao, M., & Ganesh, K. N. (2002) · Accounts of Chemical Research · doi:10.1021/ar010094x · Cited by 185
Dhiman, S., Jain, A., Kumar, M., & George, S. J. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b07469 · Cited by 184
Gene-based vaccines and immunotherapeutics
Liu, M., Acres, B., Balloul, J.-M., Bizouarne, N., Paul, S., Slos, P., & Squiban, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404845101 · Cited by 182
Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts
Yamashita, K., McDaid, J., Öllinger, R., Tsui, T., Berberat, P. O., Usheva, A., Csizmadia, E., Smith, R. N., Soares, M. P., & Bach, F. H. (2004) · The FASEB Journal · doi:10.1096/fj.03-0839fje · Cited by 180
Yan, L.-T., & Xie, X.-M. (2013) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2012.05.001 · Cited by 179
Zhang, R., Zhu, Z., Lv, H., Li, F., Sun, S., Li, J., & Lee, C. (2019) · Small · doi:10.1002/smll.201903881 · Cited by 176
Zhang, J., Li, S., An, F.-F., Liu, J., Jin, S., Zhang, J.-C., Wang, P. C., Zhang, X., Lee, C.-S., & Liang, X.-J. (2015) · Nanoscale · doi:10.1039/c5nr03259h · Cited by 175
Endres, T. K., Beck-Broichsitter, M., Samsonova, O., Renette, T., & Kissel, T. H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.064 · Cited by 175
Contribution of Aromatic Interactions to α-Helix Stability
Butterfield, S. M., Patel, P. R., & Waters, M. L. (2002) · Journal of the American Chemical Society · doi:10.1021/ja026668q · Cited by 172
Javeed, A., Ashraf, M., Riaz, A., Ghafoor, A., Afzal, S., & Mukhtar, M. M. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.08.009 · Cited by 172
Zhang, J., Liang, Y.-C., Lin, X., Zhu, X., Yan, L., Li, S., Yang, X., Zhu, G., Rogach, A. L., Yu, P. K. N., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b02513 · Cited by 169
RNA Nanotechnology-Mediated Cancer Immunotherapy
Lin, Y.-X., Wang, Y., Blake, S., Yu, M., Mei, L., Wang, H., & Shi, J. (2020) · Theranostics · doi:10.7150/thno.35568 · Cited by 169
Li, Y., Yue, T., Yang, K., & Zhang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.044 · Cited by 166
Intrinsic Resistance of Solid Tumors to Immune Checkpoint Blockade Therapy
Zhao, X., & Subramanian, S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2379 · Cited by 162
Luo, C., Sun, B., Wang, C., Zhang, X., Chen, Y., Chen, Q., Yu, H., Zhao, H., Sun, M., Li, Z., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.001 · Cited by 161
Chemotherapy agent-unsaturated fatty acid prodrugs and prodrug-nanoplatforms for cancer chemotherapy
Sun, B., Luo, C., Cui, W., Sun, J., & He, Z. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.034 · Cited by 160
Wu, H., Jin, H., Wang, C., Zhang, Z., Ruan, H., Sun, L., Yang, C., Li, Y., Qin, W., & Wang, C. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b16844 · Cited by 159
Chemotherapy-induced metastasis: mechanisms and translational opportunities
Karagiannis, G. S., Condeelis, J. S., & Oktay, M. H. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-017-9870-x · Cited by 159
Wang, M., Zhai, Y., Ye, H., Lv, Q., Sun, B., Luo, C., Jiang, Q., Zhang, H., Xu, Y., Jing, Y., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b02096 · Cited by 158
Self-citationMacrophage‐Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention
Zhou, X., Liu, X., & Huang, L. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202006220 · Cited by 158
Self-citationHönigsmann, H. (2001) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2001.00828.x · Cited by 150
Designer combination therapy for cancer
Lane, D. P. (2006) · Nature Biotechnology · doi:10.1038/nbt0206-163 · Cited by 145
Guo, Y., Jiang, K., Shen, Z., Zheng, G., Fan, L., Zhao, R., & Shao, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b14755 · Cited by 143
Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance
Zhao, Y., Chen, F., Pan, Y., Li, Z., Xue, X., Okeke, C. I., Wang, Y., Li, C., Peng, L., Wang, P. C., et al. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b05347 · Cited by 141
Wang, K., Ye, H., Zhang, X., Wang, X., Yang, B., Luo, C., Zhao, Z., Zhao, J., Lu, Q., Zhang, H., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120224 · Cited by 141
Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy
Zhao, Y., Fay, F., Hak, S., Perez‐Aguilar, J. M., Sánchez-Gaytán, B. L., Brandon, G., Duivenvoorden, R., Davies, C. D. L., Bjørkøy, A., Weinstein, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms11221 · Cited by 138
Engineering opportunities in cancer immunotherapy
Jeanbart, L., & Swartz, M. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508516112 · Cited by 135
Wen, Y. F., Zhang, W., Gong, N., Wang, Y., Guo, H., Guo, W., Wang, P. C., & Liang, X. (2017) · Nanoscale · doi:10.1039/c7nr03129g · Cited by 135
Carrier-free functionalized multidrug nanorods for synergistic cancer therapy
Zhou, M., Zhang, X., Yang, Y., Liu, Z., Tian, B., Jie, J., & Zhang, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.080 · Cited by 134
Hu, L., Cao, Z., Ma, L., Liu, Z., Liao, G., Wang, J., Shen, S., Li, D., & Yang, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119469 · Cited by 132
The Role of TLR4 in Chemotherapy-Driven Metastasis
Ran, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3525 · Cited by 118
Ye, S., Wang, F., Fan, Z., Zhu, Q., Tian, H., Zhang, Y., Jiang, B., Hou, Z., Li, Y., & Su, G. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b00897 · Cited by 113
Lv, W., Chen, N., Lin, Y., Ma, H., Ruan, Y., Li, Z., Li, X., Pan, X., & Tian, X. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.005 · Cited by 110
Albumin-coated nanocrystals for carrier-free delivery of paclitaxel
Park, J., Sun, B., & Yeo, Y. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.040 · Cited by 110
Wegiel, B., Gallo, D. J., Csizmadia, E., Roger, T., Kaczmarek, E., Harris, C. E., Zuckerbraun, B. S., & Otterbein, L. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108571108 · Cited by 109
Sayour, E. J., Grippin, A., Leon, G. D., Stover, B. D., Rahman, M., Karachi, A., Wummer, B. M., Moore, G. L., Castillo‐Caro, P., Fredenburg, K. M., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b02179 · Cited by 109
Barua, S., & Mitragotri, S. (2013) · ACS Nano · doi:10.1021/nn403913k · Cited by 106
Xiao, Y., Liu, J., Guo, M., Zhou, H., Jin, J., Liu, J., Liu, Y., Zhang, Z., & Chen, C. (2018) · Nanoscale · doi:10.1039/c8nr02700e · Cited by 105
Sun, B., Chen, Y., Han, Y., Wang, C., Zhang, X., Zhao, H., Chen, Q., He, Z., Luo, C., & Sun, J. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.008 · Cited by 105
Carrier-free nano-integrated strategy for synergetic cancer anti-angiogenic therapy and phototherapy
Wei, Z., Liang, P., Xie, J., Song, C., Tang, C., Wang, Y., Yin, X., Cai, Y., Han, W., & Dong, X. (2019) · Chemical Science · doi:10.1039/c8sc04123g · Cited by 102
Recent advances in small molecule based cancer immunotherapy
Cheng, B., Yuan, W., Su, J., Liu, Y., & Chen, J. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.028 · Cited by 101
Yu, C., Zhou, M., Zhang, X., Wei, W., Chen, X., & Zhang, X. (2015) · Nanoscale · doi:10.1039/c5nr00290g · Cited by 99
Zheng, X., Zhao, Y., Jia, Y., Shao, D., Zhang, F., Sun, M., Dawulieti, J., Hu, H., Cui, L., Pan, Y., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120716 · Cited by 97
Simple Peptide‐Tuned Self‐Assembly of Photosensitizers towards Anticancer Photodynamic Therapy
Liu, K., Xing, R., Zou, Q., Ma, G., Möhwald, H., & Yan, X. (2016) · Angewandte Chemie · doi:10.1002/ange.201509810 · Cited by 97
Li, Z., Li, S., Guo, Y., Yuan, C., Yan, X., & Schanze, K. S. (2021) · ACS Nano · doi:10.1021/acsnano.0c09913 · Cited by 96
Twelves, C. J., Jové, M., Gombos, A., & Awada, A. H. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.01.021 · Cited by 91
Chen, F., Zhao, Y., Pan, Y., Xue, X., Zhang, X., Kumar, A., & Liang, X. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500744m · Cited by 90
Hu, S., Lee, E., Wang, C., Wang, J., Zhou, Z., Li, Y., Li, X., Tang, J., Lee, D. H., Liu, X., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.031 · Cited by 82
Construction of a Supramolecular Drug–Drug Delivery System for Non-Small-Cell Lung Cancer Therapy
Zhang, Z., Shi, L., Wu, C., Su, Y., Qian, J., Deng, H., & Zhu, X. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b07565 · Cited by 81
Verissimo, T. V., Santos, N. T., Silva, D., et al. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.04.030 · Cited by 79
Glas, M., Coch, C., Trageser, D., Dassler, J., Simon, M., Koch, P., Mertens, J., Quandel, T., Gorris, R., Reinartz, R., et al. (2013) · Stem Cells · doi:10.1002/stem.1350 · Cited by 76
Boronic Acid-Appended Molecular Glues for ATP-Responsive Activity Modulation of Enzymes
Okuro, K., Sasaki, M., & Aida, T. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b02664 · Cited by 74
Wang, T., Hu, J., Luo, H., Li, H., Zhou, J., Zhou, L., & Wei, S. (2018) · Small · doi:10.1002/smll.201802337 · Cited by 74
Nanotherapeutics for Antimetastatic Treatment
Yang, F., Zhao, Z., Sun, B., Chen, Q., Sun, J., He, Z., & Luo, C. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.05.001 · Cited by 74
Pathogen-derived immunomodulatory molecules: future immunotherapeutics?
Fallon, P. G., & Alcamí, A. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.08.002 · Cited by 72
Kosharskyy, B., Solban, N., Chang, S. K., Rizvi, I., Chang, Y., & Hasan, T. G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1793 · Cited by 71
Carrier-free, functionalized drug nanoparticles for targeted drug delivery
Li, W., Yang, Y., Wang, C., Liu, Z., Zhang, X., An, F., Diao, X., Hao, X., & Zhang, X. (2012) · Chemical Communications · doi:10.1039/c2cc33214k · Cited by 70
Xiong, H., Wang, Z., Wang, C., & Yao, J. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b05008 · Cited by 69
Zhang, X., Xiong, J., Wang, K., Han, Y., Sun, B., Ye, H., Zhao, Z., Wang, N., Wang, Y., Zhang, S., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.01.004 · Cited by 65
Zhang, X., Sun, B., Zuo, S., Chen, Q., Gao, Y. L., Zhao, H., Sun, M., Chen, P., Han, Y., Zhang, W., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b10421 · Cited by 63
Liu, X., Wang, D., Zhang, P., & Li, Y. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100801 · Cited by 62
Zhang, C., Long, L., Xiong, Y., Wang, C., Peng, C., Yuan, Y., Liu, Z.-R., Lin, Y., Jia, Y., Zhou, X. W., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b22336 · Cited by 61
Self-citationXiao, H., Guo, Y., Liu, H., Liu, Y., Wang, Y.-M., Li, C., Císař, J., Škoda, D., Kuřitka, I., Guo, L., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119701 · Cited by 60
Zhao, D., Tao, W., Li, S., Li, L., Sun, Y., Li, G., Wang, G., Wang, Y., Lin, B., Luo, C., et al. (2020) · Nanoscale Horizons · doi:10.1039/d0nh00034e · Cited by 58
Self-citationGreen Mass Production of Pure Nanodrugs via an Ice-Template-Assisted Strategy
Zhang, J., Nie, W., Chen, R., Chelora, J., Wan, Y., Cui, X., Zhang, X., Zhang, W., Chen, X., Xie, H., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03043 · Cited by 57
Zhang, T., Yang, S., & Du, J. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/849783 · Cited by 56
Liu, Z., Zheng, Q., Chen, W., Wu, M., Pan, G., Ke, Y., Li, X., Man, S., Teng, Y., Yu, P., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.066 · Cited by 55
Koishi, T., Yasuoka, K., Ebisuzaki, T., Yoo, S., & Zeng, X. C. (2005) · The Journal of Chemical Physics · doi:10.1063/1.2102906 · Cited by 53
The nanomedicine rush: New strategies for unmet medical needs based on innovative nano DDS
Sato, Y., Nakamura, T., Yamada, Y., & Harashima, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.032 · Cited by 50
Du, X., Hou, Y., Huang, J., Pang, Y., Ruan, C., Wu, W., Xu, C., Zhang, H., Yin, L., & He, W. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.014 · Cited by 45
Systemic Combination Chemotherapy in Elderly Pancreatic Cancer: a Review
Garcia, G., & Odaimi, M. (2017) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-017-9930-0 · Cited by 42
Wang, Q., Sun, M., Li, D., Li, C., Luo, C., Wang, Z., Zhang, W., Yang, Z., Yao, F., Wang, S., et al. (2020) · Theranostics · doi:10.7150/thno.42633 · Cited by 38
Si, Y., Yuan, P., Hu, N., Wang, X. L., Ju, J., Wang, J., Ma, F., Luo, Y., Zhang, P., Li, Q., et al. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-019-08092-2 · Cited by 32
Complex adaptive therapeutic strategy (CATS) for cancer
Cho, Y. W., Kim, S. Y., Kwon, I. C., & Kim, I.-S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.017 · Cited by 20
Zhu, Z., Jia, J., Lu, R., Lu, Y., Fu, Z., Zhao, L., Wang, L., Jin, M., Zhao, L., Gao, W., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21501 · Cited by 18
Shi, Y., Elkhabaz, A., Yengej, F. A. Y., van den Dikkenberg, J. B., Hennink, W. E., & van Nostrum, C. F. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400455 · Cited by 18
Guo, F., Fan, Z., Yang, J., Li, Y., Wang, Y., Hai, Z., Xie, L., & Hou, Z. (2016) · Nanoscale Research Letters · doi:10.1186/s11671-016-1599-y · Cited by 17
Cited by
Feng, C., Wang, Y., Xu, J., Zheng, Y., Zhou, W., Wang, Y., & Luo, C. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121582 · Cited by 317
Samad, M. A., Ahmad, I., Zughaibi, T. A., Suhail, M., Zaidi, S. K., Al-Abbasi, F. A., & Tabrez, S. (2025) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2025.100268 · Cited by 35
Ming, H., Li, B., Tian, H., Zhou, L., Jiang, J., Zhang, T., Qiao, L., Wu, P., Nice, E. C., Zhang, W., et al. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100289 · Cited by 33
Metadata
- Authors
- Fu, S., Li, G., Zang, W., Zhou, X., Shi, K., & Zhai, Y.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2022-01
- Volume
- 12
- Issue
- 1
- Pages
- 92-106
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W3193528666
- Cited by
- 266
- References
- 166
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.